16 Berenbaum hypothesized that the therapeutic potential of GLP-1 in OA may arise from targeting the crosstalk between macrophages and fibroblasts, which are known to drive inflammation, fibrosis, and downstream cartilage damage
There are currently no population-based studies on Melanotan to indicate the extent of its use, however, there are reports of its increased off-label use in the UK
Absorption can be variable, making consistent dosing and follow-up essential
In patients with established ASCVD, clinicians should consider using GLP-1RAs or SGLT2is with proven CVD benefit, independent of baseline HbA 1c , individualized A1C target, or metformin use [15, 17]
Cagrilintide is supplied as research-grade material with 99.9% purity and is intended strictly for laboratory research use